Blood Screening Market

Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2025

Report Code: MD 3687 Jun, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Blood Screening Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Blood Screening Market

Request For Special Pricing

[253 Pages Report] The blood screening market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%. The increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are the factors majorly driving the growth of this market.

Blood Screening Market

Reagents and kits segment to witness the highest growth during the forecast period

Based on product & service, the blood screening market is segmented into reagents and kits, instruments, and software and services. The reagents and kits segment has shown the highest growth in the blood screening market and is expected to continue to grow over the forecasted period. This growth is attributed to the accessibility of a wide range of reagents and the need for reliable, specific, and fast detection of TTIs. In addition, the mandate for ELISA testing in several countries, the rising number of blood donations, and the growing demand for blood transfusion for treating blood disorders have contributed to the market growth.

NAT segment accounted for the largest share of the blood screening market, by technology, in 2019

Based on technology, the blood screening market is segmented into NAT, ELISA, rapid tests, western blot assays, and NGS. The NAT segment accounted for the larger market share in 2019 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing number of blood donations and the increasing adoption of NAT technology due to its higher sensitivity over other blood screening technologies.

Blood Screening Market by Region

North America is the largest regional market for blood screening

On the basis of region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest market share, followed by Europe. Factors such as the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the blood screening market in North America.

Key Market Players

Prominent players in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMιrieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc.(US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

Roche Diagnostics is the leading company in the market in 2019. The company is one of the leading providers in the NAT blood screening segment. The company focuses on product launches to leverage growth opportunities in the blood screening market. It also focuses on developing tests for infectious diseases. For instance, in 2017, Roche launched the screening test, Cobas Zika. It also focuses on developing tests for HIV, HBV, Zika Virus, Babesia virus, and HCV.

Scope of the Report

Report Metric

Details

Market size available for years

2016–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Product & service, technology, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America and the Middle East and Africa

Companies covered

Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMιrieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Ortho Clinical Diagnostics, Inc. (US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

This report categorizes the blood screening market into the following segments and subsegments:

By Product & Service

  • Reagents and Kits
  • NAT Reagents and Kits
    • Enzymes and Polymerases
    • Standards and Controls
    • Probes and Primers
    • Buffers, Nucleotides, and Solutions
    • Labeling and Detection Reagents
  • ELISA Reagents and Kits
    • Immunosorbents
    • Controls
    • Conjugates
    • Substrates
    • Sample Diluents and Wash Solutions
  • Other Reagents and Kits
  • Instruments
  • Outright Purchase
  • Rental Purchase
  • Software and Services

By Technology

  • NAT
    • Transcription-Mediated Amplification
    • Real-time Polymerase Chain Reaction
  • ELISA
    • Chemiluminescent Immunoassay
    • Fluorescent immunoassay
    • Colorimetric Immunoassay
  • Rapid Tests
  • Western Blot Assays
  • NGS

By End User

  • Blood Banks
  • Hospitals

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • RoLATAM
  • Middle East & Africa

Recent Developments

  • In September 2019, The US FDA approved cobas Babesia, Roche’s first whole-blood test for donor screening, in accordance with May 2019 FDA-updated industry guidance recommending screening and testing for Babesia.
  • In February 2019, Grifols received FDA approval for the Procleix Babesia Assay for donor screening on its Procleix Panther System.
  • In October 2016, Merck opened a new Life Science Center in Burlington, Massachusetts, to serve as a regional hub for scientific advancement and customer collaboration.

Key Questions Addressed by the Report

  • Where will these developments take the industry in the mid-to-long term?
  • What are the recent trends affecting the blood screening market?
  • Who are the key players in the market, and how intense is the competition?
  • What are the key applications of blood screening instruments and consumables?
  • Which region is lucrative for the blood screening market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 42)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           TABLE 1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 45)
    2.1 RESEARCH DATA
    2.2 RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION
           2.3.1 BOTTOM-UP APPROACH
                    FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.3.2 TOP-DOWN APPROACH
                    FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
           2.3.3 GROWTH FORECAST
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 4 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 52)
     FIGURE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
     FIGURE 6 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
     FIGURE 7 BLOOD SCREENING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
     FIGURE 8 BLOOD SCREENING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 55)
    4.1 BLOOD SCREENING MARKET OVERVIEW
           FIGURE 9 INCREASING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
    4.2 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD BILLION)
           FIGURE 10 REAGENTS & KITS SEGMENT DOMINATES THE BLOOD SCREENING MARKET
    4.3 BLOOD SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 11 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 57)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing demand for donated blood and rising number of blood donations
                                TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
                    5.2.1.2 Rising prevalence of infectious diseases and the emergence of newer pathogens
           5.2.2 OPPORTUNITIES
                    5.2.2.1 Technological advancements
                    5.2.2.2 Emerging economies
           5.2.3 CHALLENGES
                    5.2.3.1 Need for reducing blood screening prices
    5.3 COVID-19 IMPACT ON THE BLOOD SCREENING MARKET
    5.4 ADJACENT MARKETS
           TABLE 3 ADJACENT MARKETS FOR BLOOD SCREENING MARKET (USD MILLION)

6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE (Page No. - 62)
    6.1 INTRODUCTION
           TABLE 4 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
           TABLE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
    6.2 REAGENTS & KITS
           TABLE 6 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 7 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION)
           TABLE 8 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 9 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           6.2.1 NAT REAGENTS & KITS
                    6.2.1.1 High sensitivity and rising use of NAT are boosting demand for related reagents and kits
                               TABLE 10 NAT REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 11 NAT REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION)
                               TABLE 12 NAT REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 13 NAT REAGENTS & KITS MARKET, BY TYPE, 2021–2025 (USD MILLION)
                    6.2.1.2 Enzymes & polymerases
                    6.2.1.3 Standards & controls
                    6.2.1.4 Probes & primers
                    6.2.1.5 Buffers, nucleotides, and solutions
                    6.2.1.6 Labeling & detection reagents
           6.2.2 ELISA REAGENTS & KITS
                    6.2.2.1 Ease of use and cost-effectiveness of ELISA reagents & kits will drive market growth
                               TABLE 14 ELISA REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 15 ELISA REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION)
                               TABLE 16 ELISA REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 17 ELISA REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                    6.2.2.2 Immunosorbents
                    6.2.2.3 Controls
                    6.2.2.4 Conjugates
                    6.2.2.5 Substrates
                    6.2.2.6 Sample diluents & wash solutions
           6.2.3 OTHER REAGENTS & KITS
                    6.2.3.1 Increasing use of western blot tests and rapid tests will drive the growth of this market segment
                               TABLE 18 OTHER REAGENTS & KITS MARKET, BY REGION, 2018–2020 (USD MILLION)
                               TABLE 19 OTHER REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION)
    6.3 INSTRUMENTS
           TABLE 20 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 21 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION)
           TABLE 22 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
           TABLE 23 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
           6.3.1 RENTAL PURCHASE
                    6.3.1.1 Convenience and cost-effectiveness of renting instruments has resulted in a greater end-user preference
                               TABLE 24 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 25 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2020–2025 (USD MILLION)
           6.3.2 OUTRIGHT PURCHASE
                    6.3.2.1 Availability of government support will increase the outright purchase of instruments
                               TABLE 26 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 27 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2020–2025 (USD MILLION)
    6.4 SOFTWARE & SERVICES
           6.4.1 INCREASING ADOPTION OF INSTRUMENTS WILL DRIVE THE DEMAND FOR RELATED SOFTWARE AND SERVICES
                      TABLE 28 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
                      TABLE 29 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)

7 BLOOD SCREENING MARKET, BY TECHNOLOGY (Page No. - 76)
    7.1 INTRODUCTION
           TABLE 30 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
           TABLE 31 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
    7.2 NUCLEIC ACID TESTING
           TABLE 32 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2016–2019 (USD MILLION)
           TABLE 33 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2020–2025 (USD MILLION)
           TABLE 34 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 35 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
           7.2.1 TRANSCRIPTION-MEDIATED AMPLIFICATION
                    7.2.1.1 High sensitivity of these assays to support market growth
                               TABLE 36 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 37 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.2.2 REAL-TIME POLYMERASE CHAIN REACTION
                    7.2.2.1 Real-time PCR procedures provide more accurate and effective results as compared to conventional PCR
                               TABLE 38 REAL-TIME PCR MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 39 REAL-TIME PCR MARKET, BY REGION, 2020–2025 (USD MILLION)
    7.3 ENZYME-LINKED IMMUNOSORBENT ASSAY
           TABLE 40 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2016–2019 (USD MILLION)
           TABLE 41 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2020—2025 (USD MILLION)
           TABLE 42 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016—2019 (USD MILLION)
           TABLE 43 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
           7.3.1 CHEMILUMINESCENCE IMMUNOASSAY
                    7.3.1.1 CLIA is ultrasensitive, automated, and a good alternative to conventional methodologies
                               TABLE 44 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 45 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.2 FLUORESCENT IMMUNOASSAY
                    7.3.2.1 Rising demand for safer and stable reagents and the development of novel markers to support the growth of this market segment
                               TABLE 46 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 47 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.3 COLORIMETRIC IMMUNOASSAYS
                    7.3.3.1 CI offers low sensitivity as it uses vulnerable/limited signal amplification strategies
                               TABLE 48 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 49 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2020–2025 (USD MILLION)
    7.4 RAPID TESTS
           7.4.1 RISING AWARENESS ABOUT RAPID TESTS IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH
                    TABLE 50 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 51 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2020–2025 (USD MILLION)
    7.5 WESTERN BLOT ASSAYS
           7.5.1 GROWING PREVALENCE OF TTIS IN DEVELOPING COUNTRIES HAS RESULTED IN THE INCREASED DEMAND FOR WESTERN BLOT ASSAYS
                    TABLE 52 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 53 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2020–2025 (USD MILLION)
    7.6 NEXT-GENERATION SEQUENCING
           7.6.1 NGS IS AN EMERGING TECHNOLOGY IN THE BLOOD SCREENING MARKET
                    TABLE 54 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 55 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2020–2025 (USD MILLION)

8 BLOOD SCREENING MARKET, BY END USER (Page No. - 90)
    8.1 INTRODUCTION
           TABLE 56 BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
           TABLE 57 BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
    8.2 BLOOD BANKS
           8.2.1 BLOOD BANKS HOLD THE LARGEST SHARE OF THE BLOOD SCREENING MARKET
                    TABLE 58 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 59 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2020–2025 (USD MILLION)
    8.3 HOSPITALS
           8.3.1 INCREASING G NUMBER OF SURGICAL PROCEDURES WILL DRIVE THE GROWTH OF THE HOSPITALS SEGMENT
                    TABLE 60 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 61 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2020–2025 (USD MILLION)

9 BLOOD SCREENING MARKET, BY REGION (Page No. - 94)
    9.1 INTRODUCTION
           TABLE 62 BLOOD SCREENING MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 63 BLOOD SCREENING MARKET, BY REGION, 2020–2025 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 12 NORTH AMERICA: BLOOD SCREENING MARKET SNAPSHOT
           TABLE 64 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 65 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           TABLE 66 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
           TABLE 67 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
           TABLE 68 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 69 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 70 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
           TABLE 71 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
           TABLE 72 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
           TABLE 73 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           TABLE 74 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 75 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 76 NORTH AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
           TABLE 77 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
           TABLE 78 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
           TABLE 79 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.2.1 US
                    9.2.1.1 The US dominates the global blood screening market
                    9.2.1.2 COVID-19 Impact Analysis
                                TABLE 80 INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025
                                TABLE 81 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                                TABLE 82 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                TABLE 83 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                                TABLE 84 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                                TABLE 85 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                                TABLE 86 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                                TABLE 87 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                                TABLE 88 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                TABLE 89 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                                TABLE 90 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                TABLE 91 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                                TABLE 92 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                                TABLE 93 US: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                                TABLE 94 US: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Growing volume of surgical procedures performed and the high burden of cancer to support market growth
                    9.2.2.2 COVID-19 Impact Analysis
                                TABLE 95 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                                TABLE 96 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                TABLE 97 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                                TABLE 98 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                                TABLE 99 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 100 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 101 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 102 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 103 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 104 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 105 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 106 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 107 CANADA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 108 CANADA: BLOOD SCREENING MARKET, BY END USER, 2020–2025(USD MILLION)
    9.3 EUROPE
           TABLE 109 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 110 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           TABLE 111 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
           TABLE 112 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
           TABLE 113 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 114 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 115 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
           TABLE 116 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
           TABLE 117 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
           TABLE 118 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           TABLE 119 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 120 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 121 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
           TABLE 122 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
           TABLE 123 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
           TABLE 124 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany is the largest market for blood screening technologies in Europe
                    9.3.1.2 COVID-19 Impact Analysis
                               TABLE 125 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 126 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 127 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 128 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 129 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 130 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 131 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 132 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 133 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 134 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 135 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 136 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 137 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 138 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.3.2 FRANCE
                    9.3.2.1 Increasing prevalence of HIV to support market growth
                               TABLE 139 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019(USD MILLION)
                               TABLE 140 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 141 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 142 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 143 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 144 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 145 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 146 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 147 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 148 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 149 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 150 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 151 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 152 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2020–2025(USD MILLION)
           9.3.3 UK
                    9.3.3.1 Government support to prevent transmission of HIV and other infections will drive market growth
                    9.3.3.2 COVID-19 Impact Analysis
                               TABLE 153 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 154 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 155 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 156 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 157 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 158 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 159 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 160 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 161 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 162 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 163 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 164 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 165 UK: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 166 UK: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Italy is witnessing an increase in the number of blood donors
                    9.3.4.2 COVID-19 Impact Analysis
                               TABLE 167 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 168 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 169 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 170 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 171 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 172 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 173 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 174 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 175 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 176 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 177 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 178 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 179 ITALY: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 180 ITALY: BLOOD SCREENING MARKET, BY END USER, 2020–2025(USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increasing adoption of NAT technology will support market growth
                               TABLE 181 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 182 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 183 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 184 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 185 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 186 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 187 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 188 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 189 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 190 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 191 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 192 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 193 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 194 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 195 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                    TABLE 196 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                    TABLE 197 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 198 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 199 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                    TABLE 200 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                    TABLE 201 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                    TABLE 202 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                    TABLE 203 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 204 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 205 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                    TABLE 206 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                    TABLE 207 ROE: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                    TABLE 208 ROE: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 13 ASIA PACIFIC: BLOOD SCREENING MARKET SNAPSHOT
           TABLE 209 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 210 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           TABLE 211 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
           TABLE 212 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
           TABLE 213 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 214 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 215 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
           TABLE 216 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
           TABLE 217 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
           TABLE 218 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           TABLE 219 ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 220 ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 221 ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
           TABLE 222 ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
           TABLE 223 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
           TABLE 224 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China has a high prevalence of infectious diseases
                    9.4.1.2 COVID-19 Impact Analysis
                               TABLE 225 CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 226 CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 227 CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 228 CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 229 CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 230 CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 231 CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 232 CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 233 CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 234 CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 235 CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 236 CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 237 CHINA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 238 CHINA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Japan has witnessed an increase in the adoption of advanced blood screening technologies
                    9.4.2.2 COVID-19 Impact Analysis
                               TABLE 239 JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 240 JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 241 JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 242 JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 243 JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 244 JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 245 JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 246 JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 247 JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 248 JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 249 JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 250 JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 251 JAPAN: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 252 JAPAN: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Increasing number of road accidents will support market growth
                    9.4.3.2 COVID-19 Impact Analysis
                               TABLE 253 INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 254 INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 255 INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 256 INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 257 INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 258 INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 259 INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 260 INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 261 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 262 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 263 INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 264 INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 265 INDIA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 266 INDIA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Rising number of blood donations will propel market growth
                               TABLE 267 AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 268 AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 269 AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 270 AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 271 AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 272 AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 273 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 274 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 275 AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 276 AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 277 AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 278 AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 279 AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 280 AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 281 ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                    TABLE 282 ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                    TABLE 283 ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 284 ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 285 ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                    TABLE 286 ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                    TABLE 287 ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                    TABLE 288 ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                    TABLE 289 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 290 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 291 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                    TABLE 292 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                    TABLE 293 ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                    TABLE 294 ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
    9.5 LATIN AMERICA
           TABLE 295 LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 296 LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           TABLE 297 LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
           TABLE 298 LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
           TABLE 299 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 300 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 301 LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
           TABLE 302 LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
           TABLE 303 LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
           TABLE 304 LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           TABLE 305 LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 306 LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 307 LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
           TABLE 308 LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
           TABLE 309 LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
           TABLE 310 LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Increasing incidence of cancer will support the growth of this market
                               TABLE 311 INCIDENCE OF VARIOUS CANCERS IN BRAZIL, 2018 VS. 2025
                               TABLE 312 BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                               TABLE 313 BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                               TABLE 314 BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 315 BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 316 BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                               TABLE 317 BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                               TABLE 318 BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                               TABLE 319 BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                               TABLE 320 BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 321 BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 322 BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                               TABLE 323 BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                               TABLE 324 BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                               TABLE 325 BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.5.2 REST OF LATIN AMERICA
                    TABLE 326 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                    TABLE 327 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                    TABLE 328 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 329 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 330 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                    TABLE 331 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                    TABLE 332 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                    TABLE 333 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                    TABLE 334 REST OF LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 335 REST OF LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 336 REST OF LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                    TABLE 337 REST OF LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                    TABLE 338 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                    TABLE 339 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 RISING PREVALENCE OF INFECTIOUS DISEASES WILL DRIVE MARKET GROWTH IN THE REGION
                    TABLE 340 MEA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
                    TABLE 341 MEA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                    TABLE 342 MEA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 343 MEA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 344 MEA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION)
                    TABLE 345 MEA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION)
                    TABLE 346 MEA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                    TABLE 347 MEA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                    TABLE 348 MEA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 349 MEA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 350 MEA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION)
                    TABLE 351 MEA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION)
                    TABLE 352 MEA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION)
                    TABLE 353 MEA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 189)
     10.1 OVERVIEW
             FIGURE 14 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019
     10.2 MARKET SHARE ANALYSIS, 2019
             10.2.1 MARKET SHARE ANALYSIS FOR NAT BLOOD SCREENING, 2019
                       FIGURE 15 NAT BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
             10.2.2 MARKET SHARE ANALYSIS FOR TOTAL BLOOD SCREENING, 2019
                       FIGURE 16 BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
     10.3 COMPETITIVE SCENARIO
             10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019)
             10.3.2 PRODUCT LAUNCHES (2017–2019)
             10.3.3 EXPANSIONS (2017–2019)
             10.3.4 ACQUISITIONS (2017–2019)
     10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
             10.4.1 VENDOR INCLUSION CRITERIA
             10.4.2 VISIONARY LEADERS
             10.4.3 INNOVATORS
             10.4.4 DYNAMIC DIFFERENTIATORS
             10.4.5 EMERGING COMPANIES
                       FIGURE 17 BLOOD SCREENING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019

11 COMPANY PROFILES (Page No. - 196)
(Business Overview, Products Offered, Recent Developments, and MnM View)*
     11.1 GRIFOLS
              FIGURE 18 GRIFOLS: COMPANY SNAPSHOT (2019)
     11.2 F. HOFFMANN-LA ROCHE
              FIGURE 19 F. HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2019)
     11.3 ABBOTT LABORATORIES
              FIGURE 20 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
     11.4 BIOMΙRIEUX
              FIGURE 21 BIOMΙRIEUX: COMPANY SNAPSHOT (2018)
     11.5 BIO-RAD LABORATORIES
              FIGURE 22 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
     11.6 BECTON, DICKSON AND COMPANY
              FIGURE 23 BECTON, DICKSON AND COMPANY: COMPANY SNAPSHOT (2019)
     11.7 DANAHER CORPORATION
              FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
     11.8 ORTHO CLINICAL DIAGNOSTICS
     11.9 SIEMENS HEALTHINEERS
              FIGURE 25 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
     11.10 THERMO FISHER SCIENTIFIC
              FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
     11.11 DIASORIN
              FIGURE 27 DIASORIN: COMPANY SNAPSHOT (2019)
     11.12 GE HEALTHCARE
              FIGURE 28 GENERAL ELECTRIC: COMPANY SNAPSHOT (2019)
     11.13 MERCK KGAA
              FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2019)
     11.14 PERKINELMER
              FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019)
     11.15 BIO-TECHNE
              FIGURE 31 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2019)
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
     11.16 GFE
     11.17 TRINITY BIOTECH
     11.18 J. MITRA DIAGNOSTICS PVT. LTD.

12 ADJACENT/ RELATED MARKET- IMMUNOASSAY MARKET (Page No. - 233)
     12.1 INTRODUCTION
     12.2 IMMUNOASSAY MARKET
             12.2.1 MARKET DEFINITION
             12.2.2 LIMITATIONS
             12.2.3 MARKET OVERVIEW
     12.3 IMMUNOASSAY MARKET, BY PRODUCT AND SERVICE
             TABLE 354 IMMUNOASSAYS MARKET, BY REGION, 2016–2023 (USD MILLION)
             TABLE 355 IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
             12.3.1 REAGENTS & KITS
                       TABLE 356 IMMUNOASSAY REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
                       12.3.1.1 Reagents & Kits Market, By Type
                                   TABLE 357 IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
                                   12.3.1.1.1 ELISA Reagents & Kits
                                                 TABLE 358 ELISA REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
                                   12.3.1.1.2 Rapid Test Reagents & Kits
                                                 TABLE 359 RAPID TEST REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
                                   12.3.1.1.3 ELISPOT Reagents & Kits
                                                 TABLE 360 ELISPOT REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
                                   12.3.1.1.4 Western blot reagents & kits
                                                 TABLE 361 WESTERN BLOT REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
                                   12.3.1.1.5 Other reagents & kits
                                                 TABLE 362 OTHER REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
     12.4 ANALYZERS
              TABLE 363 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2016–2023 (USD MILLION)
              TABLE 364 IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
             12.4.1 OPEN-ENDED SYSTEMS
                        TABLE 365 OPEN-ENDED SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
             12.4.2 CLOSED-ENDED SYSTEMS

                        TABLE 366 CLOSED-ENDED SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
             12.4.3 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE

                        TABLE 367 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016–2023 (USD MILLION)
     12.5 SOFTWARE & SERVICES
              TABLE 368 IMMUNOASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION)
     12.6 MOLECULAR DIAGNOSTICS MARKET
             TABLE 369 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
             TABLE 370 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
     12.7 WESTERN BLOTTING MARKET
             TABLE 371 WESTERN BLOTTING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
     12.8 IN-VITRO DIAGNOSTICS MARKET
             TABLE 372 IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2019–2025 (USD MILLION)

13 APPENDIX (Page No. - 247)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the blood screening market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the blood screening market. The secondary sources used for this study include the US Food and Drug Association (US FDA), AVERT, European Commission, Red Cross, Union for International Cancer Control, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Cancer Society (ACS), Organisation for Economic Co-operation and Development (OECD), European Centre for Disease Prevention and Control (ECDC), Annual Reports, Press Releases, SEC Filings, Expert Interviews, and Investor Presentations. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Blood Screening Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood screening market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the blood screening market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the blood screening market on the basis of product & service, technology, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the overall blood screening market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such acquisitions; product launches; expansions; agreements, partnerships, and collaborations; and R&D activities in the blood screening market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Blood screening market size and growth rate estimates for counties in Rest of Europe and the Rest of Asia Pacific

Company profiles

  • Additional five company profiles of players operating in the blood screening market
Report Code
MD 3687
Published ON
Jun, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Blood Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home